SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001548233-12-000021
Filing Date
2012-11-19
Accepted
2012-11-19 10:00:55
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT Sept2012_10q.htm 10-Q 1016874
2 EXHIBIT 31-1 quarterly_ex31z1.htm EX-31 14359
3 EXHIBIT 32-1 quarterly_ex32z1.htm EX-32 9860
  Complete submission text file 0001548233-12-000021.txt   4607453

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctix-20120930.xml EX-101.INS 485101
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctix-20120930.xsd EX-101.SCH 47944
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctix-20120930_cal.xml EX-101.CAL 23043
7 XBRL TAXONOMY DEFINITION LINKBASE DOCUMENT ctix-20120930_def.xml EX-101.DEF 223972
8 XBRL TAXONOMY LABEL LINKBASE DOCUMENT ctix-20120930_lab.xml EX-101.LAB 370045
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctix-20120930_pre.xml EX-101.PRE 292964
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 121213375
SIC: 2834 Pharmaceutical Preparations